DK643389D0 - Endotelcellevaekstfaktor samt fremgangsmaade til oprensning deraf - Google Patents

Endotelcellevaekstfaktor samt fremgangsmaade til oprensning deraf

Info

Publication number
DK643389D0
DK643389D0 DK643389A DK643389A DK643389D0 DK 643389 D0 DK643389 D0 DK 643389D0 DK 643389 A DK643389 A DK 643389A DK 643389 A DK643389 A DK 643389A DK 643389 D0 DK643389 D0 DK 643389D0
Authority
DK
Denmark
Prior art keywords
subjecting
pooling
active fractions
resulting active
growth factor
Prior art date
Application number
DK643389A
Other languages
English (en)
Other versions
DK643389A (da
Inventor
Carl-Henrik Heldin
Kohei Miyazono
Christer Wernstedt
Ulf Hellman
Fumimaro Takaku
Fuyuki Ishikawa
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Publication of DK643389D0 publication Critical patent/DK643389D0/da
Publication of DK643389A publication Critical patent/DK643389A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK643389A 1988-12-20 1989-12-18 Endotelcellevaekstfaktor samt fremgangsmaade til oprensning deraf DK643389A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28805688A 1988-12-20 1988-12-20

Publications (2)

Publication Number Publication Date
DK643389D0 true DK643389D0 (da) 1989-12-18
DK643389A DK643389A (da) 1990-06-21

Family

ID=23105561

Family Applications (1)

Application Number Title Priority Date Filing Date
DK643389A DK643389A (da) 1988-12-20 1989-12-18 Endotelcellevaekstfaktor samt fremgangsmaade til oprensning deraf

Country Status (13)

Country Link
EP (2) EP0685490A1 (da)
JP (1) JPH02288897A (da)
KR (1) KR900009989A (da)
AT (1) ATE145242T1 (da)
AU (1) AU4687989A (da)
CA (1) CA2005600A1 (da)
DE (1) DE68927458T2 (da)
DK (1) DK643389A (da)
FI (1) FI896137A7 (da)
IL (1) IL92735A (da)
NO (1) NO895055L (da)
NZ (1) NZ231837A (da)
PT (1) PT92613B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI890342L (fi) * 1988-01-25 1989-07-26 American Cyanamid Co Hjaernmitogener, som binds till heparin.
CA2005600A1 (en) 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor
ES2123004T3 (es) * 1991-04-12 1999-01-01 Creative Biomolecules Inc Uso de factor de crecimiento derivado de plaquetas en la preparacion de un medicamento para el tratamiento de ulceras gastrointestinales.
DE4118912C1 (da) * 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De
GB9121815D0 (en) * 1991-10-15 1991-11-27 Delta Biotechnology Ltd Medicine
EP0697883A1 (en) * 1993-04-29 1996-02-28 Washington University Use of platelet-derived growth factor to improve collateral circulation
JP3268147B2 (ja) * 1994-12-28 2002-03-25 大鵬薬品工業株式会社 モノクローナル抗体
AU729459B2 (en) * 1996-11-15 2001-02-01 Genentech Inc. Purification of neurotrophins
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AUPP263498A0 (en) * 1998-03-27 1998-04-23 Walter And Eliza Hall Institute Of Medical Research, The Novel therapeutic molecules and uses therefor
ES2402144T3 (es) * 2010-05-25 2013-04-29 Gwowei Technology Co., Ltd. Lisado plaquetario inactivado que contiene factores de crecimiento empobrecido en PDGF y VEGF y su procedimiento de preparación
WO2012102100A1 (ja) 2011-01-26 2012-08-02 雪印メグミルク株式会社 感覚改善剤
HK1221402A1 (zh) 2013-04-02 2017-06-02 University Of Florida Research Foundation, Inc. 用於诱导并调节血管生成的组合物和方法以及用於鉴别血管生成调节剂的方法和实验

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2005600A1 (en) 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor

Also Published As

Publication number Publication date
DK643389A (da) 1990-06-21
DE68927458D1 (de) 1996-12-19
JPH02288897A (ja) 1990-11-28
PT92613B (pt) 1996-09-30
FI896137A7 (fi) 1990-06-21
EP0377855A2 (en) 1990-07-18
EP0685490A1 (en) 1995-12-06
EP0377855A3 (en) 1990-12-19
DE68927458T2 (de) 1997-04-03
CA2005600A1 (en) 1990-06-20
PT92613A (pt) 1990-06-29
KR900009989A (ko) 1990-07-06
NO895055D0 (no) 1989-12-15
IL92735A0 (en) 1990-09-17
EP0377855B1 (en) 1996-11-13
FI896137A0 (fi) 1989-12-20
IL92735A (en) 1998-06-15
AU4687989A (en) 1990-06-28
ATE145242T1 (de) 1996-11-15
NZ231837A (en) 1992-03-26
NO895055L (no) 1990-06-21

Similar Documents

Publication Publication Date Title
DK643389A (da) Endotelcellevaekstfaktor samt fremgangsmaade til oprensning deraf
AU4521897A (en) Purified immunoglobulins
EP0121976A3 (en) Partially purified osteogenic factor and process for preparing same from demineralized bone or an osteosarcoma
EP0168234A3 (en) Purification process for hepatitis surface antigen and product thereof
EP0212688A3 (en) Substituted and crosslinked glucans, process for preparing them and use thereof
DE3853224D1 (de) Produktion von Proteinen in aktiver Form.
DE3584536D1 (de) Vorrichtung zur steuerkraftstabilisierung bei einem drehfluegelflugzeug.
ES2093031T3 (es) Metodo para purificar el factor de crecimiento transformante (tgf).
FR2628027B1 (fr) Procede de fabrication de pieces de carrosserie d'automobile, notamment d'aileron ou becquet arriere, et pieces obtenues par mise en oeuvre de ce procede
SE7909897L (sv) Rening av gammaglobulinderivat
DE3788170D1 (de) Methode zur Reinigung und Isolierung von zwei ionischen Formen von Somatomedin.
ATE39889T1 (de) Vorrichtung zum umdrehen eines gelenkten kraftfahrzeuges.
DK1624057T3 (da) Hyaluronidaseholdigt præparat samt dets farmaceutiske anvendelse
GR3004622T3 (da)
AU551407B2 (en) Crystalline human leukocyte interferon
ATE133421T1 (de) Verfahren zur herstellung von rekombinantem humaninterferon-beta in reiner form
FR2680879B1 (fr) Procede de fabrication d'ebauches de ferrules ou de multiferrules, et ebauches obtenues par ce procede.
RU93037415A (ru) Способ промышленного получения (6s)-изомеров методом хроматографического разделения
NO915032D0 (no) Interferonrenseprosess
RO103684A2 (en) PRODUCTION METHOD OF IMMUNO-GLOBULIN A1(IgA1)
FR2341592A1 (fr) Procede de purification de l'enzyme glucuronoglycosaminoglycane hyaluronate lyase
ES1009300U (es) Grupo optico para vehiculos automoviles con fijacion graduable.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment